Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An unexpected tail of VEGF and PlGF in pre-eclampsia

21 Nov 2011

Abstract excerpt

PET (pre-eclamptic toxaemia), characterized by pregnancy-related hypertension and proteinuria, due to widespread endothelial dysfunction, is a primary cause of maternal morbidity. Altered circulating factors, particularly the VEGF (vascular endothelial growth factor) family of proteins and their receptors, are thought to be key contributors to this disease. Plasma from patients with PET induces numerous cellular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Apelin-related biomedical research
Share to Pregnancy and preeclampsia studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22103490
DOI: 10.1042/bst20110671

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An unexpected tail of VEGF and PlGF in pre-eclampsiaPMID 22103490Read ↗

Endothelial dysfunction in the pathogenesis of pre-eclampsiaSemantic proximity Read ↗

Angiogenic growth factors in the diagnosis and prediction of pre-eclampsiaSemantic proximity Read ↗

Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A165a, VEGF-A165b, PIGF and VE-cadherinSemantic proximity Read ↗

A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1Semantic proximity Read ↗

Plasma markers of angiogenesis in pregnancy induced hypertensionSemantic proximity Read ↗

The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at termSemantic proximity Read ↗

Angiogenic factors: potential to change clinical practice in pre‐eclampsia?Semantic proximity Read ↗

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic useSemantic proximity Read ↗

Growth factors in preeclampsia: A vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards?Semantic proximity Read ↗

Hypoxia and sFlt-1 in Preeclampsia: The “Chicken-and-Egg” QuestionSemantic proximity Read ↗

VEGF expression in the placenta from pregnancies complicated by hypertensive disordersSemantic proximity Read ↗

Circulating Factors as Markers and Mediators of Endothelial Cell Dysfunction in PreeclampsiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.